1.Effects of the calpain system expression on atrial structural remodeling in canine with atrial fibrillation
Xiao MA ; Wei ZHANG ; Ming ZHONG ; Li LI ; Ya MIAO ; Hui SUN ; Yun ZHANG
Chinese Journal of Pathophysiology 2000;0(10):-
AIM: To evaluate the influence of the calpain system mRNA and protein expression on the progress of atrial structural remodeling in fibrillating canine.METHODS: 17 dogs were randomly divided into 2 groups: normal control group(SR,n=6) and atrial fibrillation(AF,n=11) group.AF was induced by rapid pacing for 8 weeks and all dogs underwent transthoratic echocardiography before and after rapid pacing.The mRNA and protein expression of calpainⅠ,calpainⅡand calpastatin were assessed by real-time quantitative PCR and Western blotting,respectively.RESULTS: Compared with SR group,the left atrial diameters and the content of calcium in atrial myocardium increased significantly in AF group(P0.05) between two groups.The expression of calpastatin mRNA was upregulated significantly in AF group(P
2.Uprighting of mesially or horizontally impacted mandibular molars.
Chinese Journal of Stomatology 2006;41(1):8-11
OBJECTIVETo assess the treatment method and outcome of mesially or horizontally impacted mandibular molars.
METHODSEleven patients with mandibular impacted molars, including 9 horizontally impacted molars and 5 mesially impacted molars were treated with fixed appliance in conjunction with molar band soldered with pushing spring. Crowns of impacted molars were moved occlusally and distally.
RESULTSAll mesially or horizontally mandibular impacted molars were uprighted and brought into occlusion. Mean treatment period was 7.4 months (6 to 12 months).
CONCLUSIONSThis orthodontic molar uprighting technique was effective in uprighting and distalizing the impacted molars.
Adolescent ; Adult ; Female ; Humans ; Male ; Molar ; pathology ; physiology ; Orthodontic Appliances ; Orthodontics, Corrective ; methods ; Tooth, Impacted ; therapy ; Young Adult
3.Expression and significance of thrombospondin-1 in myocardium of type 2 diabetic cardiomyopathy rats
Ming ZHONG ; Wei ZHANG ; Ya MIAO ; Peili BU ; Hui SUN ; Xiao MA ; Huiping GONG ; Mengxiong TANG ; Yun ZHANG
Chinese Journal of Pathophysiology 1999;0(09):-
AIM:To investigate the expression and significance of thrombospondin-1(TSP-1)in left ventricular myocardium of type 2 diabetic cardiomyopathy(DCM).METHODS:The rat model of DCM was established by eating a high-fat diet together with injection of low dose streptozocin(30 mg/kg)intrapertoneally.After 12 weeks,the content of collagen was quantified by Masson staining.The mRNA level of TSP-1 was determined by quantification real-time RT-PCR,while the protein level of TSP-1 was analyzed by Western blotting and immunohistochemistry.RESULTS:Compared with the control group,the content of collagen in the DCM group was increased greatly(11.01?3.05 vs 16.92?3.18,P
4.Detection and genetic analysis of TT virus in hemodialysis patients
Wu NI ; Hao REN ; Xiao-Hui MIAO ; Zhong-Tian QI ; Chao-Yang YE
Academic Journal of Second Military Medical University 2001;22(4):331-333
Objective: To study the prevalence and pathogenesis of TT virus (TTV) in hemodialysis patients. Methods: Serum TTV DNA was tested in 69 hemodialysis patients from our hospital by nested-PCR using primers from a conservative region of TTV genenome, genetic analysis and detection of hepatitis C virus antibody (anti-HCV) and the levels of alanine aminotransferase (ALT) were also carried out simultaneously. Results: The overall prevalence of TTV viremia was 27.5%. The PCR-amplified gene fragment from one patient was sequenced, and its gene sequence homologies with GH1,TA278, TTVCHN1 and TTVCHN2 ranged from 89% to 100%, its deduced amino acid sequence ranged from 87% to 100%. There was no significant difference of TTV prevalence between anti-HCV positive and negative patients. No significant elevation of ALT was found in all patients. Conclusion: High prevalence of TTV infection is found among hemodialysis patients, and TTV infection has no significant association with HCV infection or elevation of ALT.
6.Evolutionary trace analysis of N-myristoyltransferase family.
Chun-quan SHENG ; Jie ZHU ; Wan-nian ZHANG ; Hui XU ; Zhen-yuan MIAO ; Jian-zhong YAO ; Min ZHANG
Acta Pharmaceutica Sinica 2007;42(2):157-165
To clarify the important functional residues in the active site of N-myristoyltransferase (NMT), a novel antifungal drug target, and to guide the design of specific inhibitors, multiple sequence alignments were performed on the NMT family and thus evolutionary trace was constructed. The important functional residues in myristoyl CoA binding site, catalytic center and inhibitor binding site of NMT family were identified by ET analysis. The trace residues were mapped onto the active site of CaNMT. Trpl26, Asn175 and Thr211 are highly conserved trace residues and do not interact with current NMT inhibitors, which are potential novel drug binding sites for the novel inhibitor design. Pro338, Leu350, Ile352 and Ala353 are class-specific trace residues, which are important for the optimization of current NMT inhibitors. The trace residues identified by ET analysis are of great importance to study the structure-function relationship and also to guide the design of specific inhibitors.
Acyl Coenzyme A
;
metabolism
;
Acyltransferases
;
chemistry
;
genetics
;
metabolism
;
Amino Acid Sequence
;
Animals
;
Binding Sites
;
Conserved Sequence
;
Enzyme Inhibitors
;
chemistry
;
pharmacology
;
Evolution, Molecular
;
Humans
;
Imidazoles
;
chemistry
;
pharmacology
;
Models, Molecular
;
Molecular Sequence Data
;
Oligopeptides
;
chemistry
;
pharmacology
;
Phylogeny
;
Protein Structure, Tertiary
;
Sequence Homology, Amino Acid
7.Efficacy and safety of steroid combined with immunosuppressants in the treatment of primary IgA nephropathy in children: a Meta analysis.
Jian-Mei ZHOU ; Xu-Hui ZHONG ; Xin-Miao SHI ; Jie DING
Chinese Journal of Contemporary Pediatrics 2020;22(8):860-866
OBJECTIVE:
To systematically evaluate the efficacy and safety of steroid combined with immunosuppressants in the treatment of primary IgA nephropathy in children.
METHODS:
English and Chinese electronic databases were searched to include the studies on the efficacy and safety of steroid combined with immunosuppressants versus steroid alone in the treatment of primary IgA nephropathy in children. Outcome measures included proteinuria remission rate, urinary protein quantification, incidence of adverse events, estimated glomerular filtration rate, and incidence of renal dysfunction. Review Manager 5.3 software was used for data analysis.
RESULTS:
A total of 7 studies with 381 children were included. The children had moderate to severe proteinuria. The Meta analysis showed that compared with the steroid alone group, the steroid combined with immunosuppressants group achieved a significantly higher rate of proteinuria remission (RR=1.36, 95%CI: 1.19-1.55, P<0.001) and significantly lower urinary protein quantification (SMD=-0.82, 95%CI: -1.23 to -0.41, P<0.001). There was no significant difference in the incidence rate of adverse events between the two groups (RR=1.28, 95%CI: 0.92-1.77, P=0.14).
CONCLUSIONS
The current evidence shows that for children with primary IgA nephropathy who have moderate to severe proteinuria, steroid combined with immunosuppressants has a better effect than steroid alone and does not increase the incidence rate of adverse events.
Child
;
Glomerular Filtration Rate
;
Glomerulonephritis, IGA
;
Humans
;
Immunosuppressive Agents
;
Proteinuria
8.The role of glucose/TSP-1/TGFbeta1 signal pathways in diabetic cardiomyopathy.
Ming ZHONG ; Wei ZHANG ; Ya MIAO ; Xiao MA ; Hui-ping GONG ; Hui SUN ; Meng-xiong TANG ; Yun ZHANG
Chinese Journal of Cardiology 2006;34(3):217-221
OBJECTIVEHyperglycemia could upregulate transforming growth factor-beta (TGFbeta(1)) via thrombospondin (TSP-1) and induce fibrotic renal disease in the rat in vivo and myocardial fibrosis was related to cardiac dysfunction in diabetic patients. We explored the role of glucose/TSP-1/TGFbeta(1) signal pathways in the development of diabetic cardiomyopathy (DCM).
METHODSMale Wistar rats were fed with high cholesterol diet for 17 weeks, streptozocin (30 mg/kg, i.p) was given at the 28th day, rats with fasting blood glucose > or = 11.1 mmol/L by the end of the 5th week were assigned to DCM group (n = 11). Control rats (n = 8) were fed with regular chow. Fasting blood glucose (FBG) was monitored throughout the study. After hemodynamic measurements by the end of the study, myocardial collagen content was quantified in Masson-stained samples and the mRNA expressions of TSP-1 and TGFbeta(1) were detected by quantification real-time RT-PCR. The protein levels of TSP-1, active and latent TGFbeta(1) were detected by Western blot.
RESULTSCompared with control group, cardiac function was decreased as shown by significantly reduced left ventricular systolic pressure, dp/dt(max) and dp/dt(min), while the myocardial collagen content was significantly increased in the DCM group (11.01 +/- 3.05 vs. 16.92 +/- 3.18, P < 0.01). The myocardial mRNA expressions of TSP-1, TGFbeta(1) and protein expressions of TSP-1, active and latent TGFbeta(1) in the DCM group were also significantly higher than those of the control group. Moreover, myocardial collagen was positively correlated to FBG (r = 0.746, P < 0.01); mRNA expressions of TSP-1 and TGFbeta(1), protein expressions of TSP-1 and active TGFbeta(1) were positively correlated to FBG and myocardial collagen (P < 0.05). However, there were no correlations between the protein expression of latent TGFbeta(1) and FBG and myocardial collagen.
CONCLUSIONThe pathway of glucose/TSP-1/TGFbeta(1) might play an important role in myocardial interstitial fibrosis of DCM. It may be the basis of novel therapeutic approaches for ameliorating DCM.
Animals ; Cardiomyopathies ; etiology ; metabolism ; Diabetes Mellitus, Experimental ; complications ; metabolism ; Glucose ; metabolism ; Male ; Myocardium ; metabolism ; Rats ; Rats, Wistar ; Signal Transduction ; Thrombospondin 1 ; metabolism ; Transforming Growth Factor beta1 ; metabolism
9.Relationship of epidermal growth factor receptor gene mutations, clinicopathologic features and prognosis in patients with non-small cell lung cancer.
Miao-jing FAN ; Hai-gang LI ; Zhi-qiang LÜ ; Hui-zhong ZHANG ; Xi-ming SHEN
Chinese Journal of Pathology 2011;40(10):679-682
OBJECTIVETo investigate epidermal growth factor receptor (EGFR) gene mutations in exons 19 and 21 of patients with non-small cell lung cancer (NSCLC) and to analyze the relationship of EGFR mutations with clinicopathological features and prognosis.
METHODSThe EGFR gene exons 19 and 21 of paraffin-embedded tumor tissue were amplified by PCR, followed by direct sequencing in 282 surgically-removed specimens of NSCLC. The relationship of EGFR gene mutations in NSCLC with clinicopathological features and prognosis were analyzed.
RESULTSEGFR mutations were detected in 120 of 282 (42.6%) patients with NSCLC. There were 61 cases of the mutations in exon 19 and 66 cases of the mutations in exon 21, including 7 cases of the mutations both in exons 19 and 21. Mutations were more frequently observed in women (55.2%, 53/96) than in men (36.0%, 67/186), in 51 to 60-years-old (51.3%, 39/76) than ≤50-years-old (30.4%, 21/69) and >60-years-old (43.8%, 60/137), in non-smokers (54.3%, 69/127) than smokers (32.9%, 51/155), there was negative correlation of EGFR mutations with smoking status (P=0.000, rs=-0.216). EGFR mutations were more frequently observed in adenocarcinomas (47.8%, 64/134), bronchiolo-alveolar carcinomas (73.0%, 27/37), adenosquamous carcinomas (7/9) than squamous cell carcinomas (23.6%, 17/72) and other types (16.7%, 5/30). The EGFR mutation rate in the well differentiated, the middle differentiated, the poorly differentiated and the undifferentiated was 55.7% (68/122), 50.8% (30/59), 22.7% (17/75), 19.2% (5/26) respectively, the incidences of EGFR mutations decreased with the degrading of differentiation, there was positive correlation of EGFR mutations with differentiation of lung cancer (P=0.000, rs=0.296). The patients with EGFR mutations had better prognosis than those with wild-type EGFR (P=0.027). There was no association of EGFR mutations with clinical TNM stage.
CONCLUSIONSEGFR mutations occur frequently in females, non-smokers and adenocarcinomas, bronchioloalveolar carcinomas, and adenosquamous carcinomas. The patients with EGFR mutations have better prognosis. The results may offer a practical approach to select the patients who may benefit from anti-EGFR target therapy.
Adenocarcinoma ; genetics ; Adenocarcinoma, Bronchiolo-Alveolar ; genetics ; Adult ; Age Factors ; Aged ; Aged, 80 and over ; Carcinoma, Adenosquamous ; genetics ; Carcinoma, Non-Small-Cell Lung ; genetics ; pathology ; Exons ; Female ; Gene Amplification ; Genes, erbB-1 ; Humans ; In Situ Hybridization, Fluorescence ; methods ; Lung Neoplasms ; genetics ; pathology ; Male ; Middle Aged ; Mutation ; Mutation Rate ; Polymerase Chain Reaction ; methods ; Prognosis ; Receptor, Epidermal Growth Factor ; genetics ; Sequence Analysis, DNA ; methods ; Sex Factors ; Smoking ; Survival Rate
10.Proteomic analysis of differently expressed proteins in human hepatocellular carcinoma cell lines HepG2 with transfecting hepatitis B virus X gene.
Wei-hua LI ; Xiao-hui MIAO ; Zhong-tian QI ; Wu NI ; Shi-ying ZHU ; Fang FANG
Chinese Medical Journal 2009;122(1):15-23
BACKGROUNDHepatitis B virus encoded X protein (HBx) is a trans-activating protein that may be involved in hepatocarcinogenesis, although few natural effectors of HBx that participate in this process have been identified. We screened, by comparative proteomics method, effectors of HBx associated with hepatocarcinogenesis.
METHODSHBx positive and negative HepG2 cells were constructed and expression patterns of cellular proteins were obtained by high resolution, two dimensional electrophoresis. Comprehensive analyses of proteins associated with hepatocellular carcinoma (HCC) were focused on the differently expressed proteins (more than two-fold increase or decrease, P < 0.05) from HBx positive and negative HepG2 cells. For peptide mass fingerprinting, protein spots with different intensity between HBx positive and negative HepG2 cells were directly cut out of gels and processed for matrix assisted, laser desorption/ionization, time of flight mass spectrometry and liquid chromatography-tandem mass spectrometry (LC-ESI-MS/MS) analysis.
RESULTSThe mean number of protein spots for HBx negative and HBx positive HepG2 cells were 2095 +/- 137 and 2188 +/- 105, respectively. The analysis of paired cells showed 75 spots with significant differences in expression between HBx negative and HBx positive cells: 37 spots corresponding to 32 different proteins; 25 proteins were upregulated, 7 downregulated. We found 7 proteins not previously reported differentially expressed in HBx positive HepG2 cells. Variations in protein accumulation were confirmed for four (HSP90AB1, BCL2 associated athanogene 2, nucleophosmin and chloride intracellular channel 1) by Western blotting in HBx positive HepG2 cells.
CONCLUSIONSNumerous effectors of HBx that may promote the development of HCC are identified, of which 7 are newly noted in HepG2 cells. Several of these effectors of HBx may help in elucidating the roles of HBx in hepatocarcinogenesis and diagnostics or targets for therapeutic intervention.
Blotting, Western ; Carcinoma, Hepatocellular ; genetics ; metabolism ; Cell Line, Tumor ; Electrophoresis, Gel, Two-Dimensional ; Humans ; Polymerase Chain Reaction ; Proteomics ; methods ; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization ; Trans-Activators ; genetics ; metabolism ; Viral Regulatory and Accessory Proteins ; genetics ; metabolism